Author details

Full Name

Daniel F Heitjan

Affiliation

ORCID

Career Start Year

1987

Papers

199

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37365674	Sensitivity of estimands in clinical trials with imperfect compliance.		2023
35674139	Survival of cancer survivors with a new pancreatic cancer diagnosis.	Cancer Medicine	2023
37616150	Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data.		2023
37458161	Electronic phenotypes to distinguish clinician attention to high body mass index, hypertension, lipid disorders, fatty liver and diabetes in pediatric primary care: Diagnostic accuracy of electronic phenotypes compared to masked comprehensive chart review		2023
34297356	Analysis of local sensitivity to nonignorability with missing outcomes and predictors.	Biometrics	2022
34636065	Estimating the optimal timing of surgery by imputing potential outcomes.	Statistics in Medicine	2021
33620590	Survival of women diagnosed with breast cancer and who have survived a previous cancer.	Breast Cancer Research and Treatment	2021
33875764	COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans.	Scientific Reports	2021
34190429	Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.	Cancer Medicine	2021
32506431	Estimating the optimal timing of surgery from observational data.	Biometrics	2021
34763810	PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumes.	Artif Intell Med	2021
32650671	Editorial: Clinical trial design in the era of COVID-19.	Clinical Trials	2020
32052007	Underlying Breast Cancer Risk and Menopausal Hormone Therapy.	J Clin Endocrinol Metab	2020
32099932	Flexible, rule-based dose escalation: The cohort-sequence design.	Contemporary Clinical Trials Communications	2020
32882039	Approach to Managing a Postmenopausal Patient.	J Clin Endocrinol Metab	2020
29468944	Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders.	Statistical Methods in Medical Research	2019
30411375	Statistical modeling and prediction of clinical trial recruitment.	Statistics in Medicine	2019
29687467	Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers.	Statistics in Medicine	2018
28975352	Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis.	JAMA Oncol	2018
30020469	Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids.	Journal of Clinical Endocrinology and Metabolism	2018
29975406	Statistical justification of expansion cohorts in phase 1 cancer trials.	Cancer	2018
30195428	Measuring the Impact of Nonignorable Missingness Using the R Package isni.	Comput Methods Programs Biomed	2018
30279592	Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.	Scientific Reports	2018
29376735	Adaptive parametric prediction of event times in clinical trials.	Clinical Trials	2018
28532162	Commentary on Mason et al.	Clinical Trials	2017
28545934	Cure modeling in real-time prediction: How much does it help?	Contemporary Clinical Trials	2017
28497551	Proximity and gravity: modeling heaped self-reports.	Statistics in Medicine	2017
25197014	HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery.	Head Neck	2016
26968202	Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNÎ± Combined with Chemotherapy.	Clin Cancer Res	2016
27457310	Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial.	Annals of Oncology	2016
26081923	Model-based imputation of latent cigarette counts using data from a calibration study.	International Journal of Methods in Psychiatric Research	2016
26366539	The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas.	Annals of Surgery	2015
25504852	Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.	NMR in Biomedicine	2015
25501126	CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.	Clinical Cancer Research	2015
25588294	Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.	Lancet Respir Med	2015
25702942	Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.	NMR in Biomedicine	2015
25732567	Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers.	Nicotine and Tobacco Research	2015
25568092	Suspension of accrual in phase II cancer clinical trials.	Clinical Trials	2015
26188165	Real-time prediction of clinical trial enrollment and event counts: A review.	Contemporary Clinical Trials	2015
26010901	Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.	PLoS One	2015
26126457	Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection.	Journal of Thoracic and Cardiovascular Surgery	2015
25988622	The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.	Am J Transplant	2015
25106680	Intraoperative near-infrared imaging can identify pulmonary nodules.	Ann Thorac Surg	2014
25313245	Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program.	Journal of the National Cancer Institute	2014
24991840	A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.		2014
24991839	Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.	Autophagy	2014
24991838	Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.		2014
24991834	Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.		2014
24603893	An active learning approach for rapid characterization of endothelial cells in human tumors.	PLoS ONE	2014
24587844	EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT.	Annals of Applied Statistics	2013